Heparin Sodium Injection — FDA Drug Shortage

Current — Hospira, Inc., A Pfizer Company

The FDA lists a drug shortage record for Heparin Sodium Injection (injection) from Hospira, Inc., A Pfizer Company with status Current. The shortage was first posted on Nov 14, 2017.

Shortage details

Status
Current
Company
Hospira, Inc., A Pfizer Company
Package NDC
0409-2222-12
Dosage Form
Injection
Presentation
Heparin Sodium, Injection, 2,000 Units/1,000 mL (2 Units/mL) (NDC 0409-2222-12)
Initial Posting
Nov 14, 2017

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.